Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo.
D000818:Animals; D001853:Bone Marrow / Q000378:metabolism / Q000473:pathology; D002470:Cell Survival / Q000187:drug effects; D003520:Cyclophosphamide / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000494:pharmacology / Q000627:therapeutic use; D006098:Granulocytes / Q000187:drug effects; D007413:Intestinal Mucosa / Q000378:metabolism; D007700:Kinetics; D008130:Lomustine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000378:metabolism; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism; D011741:Pyrimidine Nucleosides; D013936:Thymidine; D014529:Uridine
D004273:DNA, Neoplasm; D011741:Pyrimidine Nucleosides; D008130:Lomustine; D003520:Cyclophosphamide; D005472:Fluorouracil; D013936:Thymidine; D014529:Uridine; D008727:Methotrexate